AIGH Capital Management’s Adamas Pharmaceuticals ADMS Stock Holding History

AIGH Capital Management’s Portfolio ADMS Stock Details ADMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,585,743	Closed	-$12.7M	–	69
2021 Q3	$12.7M	Buy	2,585,743 +150,000	+6%	+$728K	2.67%	11
2021 Q2	$12.9M	Buy	2,435,743 +225,000	+10%	+$1.16M	2.32%	13
2021 Q1	$10.6M	Buy	2,210,743 +1,334,892	+152%	+$6.97M	2.23%	11
2020 Q4	$3.79M	Buy	+875,851	New	+$3.75M	1.54%	20

AIGH Capital Management's ADMS Position: Q4 2021 in Review

AIGH Capital Management sold out of Adamas Pharmaceuticals (ADMS) in Q4 2021, closing a stake of 2,585,743 shares — an estimated $12.7M sold.

AIGH Capital Management first reported a position in ADMS in Q4 2020 and held it in 4 quarters. The position peaked at $12.9M in Q2 2021. 0 funds tracked by Wall St. Rank hold ADMS as of Q4 2021.

AIGH Capital Management reported no remaining Adamas Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
AIGH Capital Management sold 2,585,743 Adamas Pharmaceuticals shares in Q4 2021, an estimated $12.7M.
AIGH Capital Management first reported a position in Adamas Pharmaceuticals in Q4 2020 and held it in 4 quarters.
AIGH Capital Management's Adamas Pharmaceuticals position peaked at $12.9M in Q2 2021.
0 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q4 2021.

Based on AIGH Capital Management's 13F filing for Q4 2021, filed 10 Feb 2022.